Genomic Health, Inc. Announces Third Quarter 2005 Financial Results Conference Call Thursday, November 3, 2005

REDWOOD CITY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that the company will host a conference call and webcast on Thursday, November 3 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its third quarter 2005 financial results. The call and webcast will follow the release of the third quarter financial results at approximately 4:00 p.m. Eastern/1:00 p.m. Pacific.

To access the live conference call via phone, please dial 800-289-0544 from the United States and Canada or 913-981-5533 internationally. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 10 and may be accessed by dialing 888-203-1112 from the United States and Canada or 719-457-0820 internationally. The replay passcode is 6244177.

Additionally, you may access the live and subsequently archived webcast of the conference call from the Investor Relations section of the Company's website at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. An archived replay of the call will be available for one year.

About Genomic Health, Inc.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. For more information, please visit www.genomichealth.com.

Genomic Health, Inc.

CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com; or media, Emily Faucette of WeissCommPartners, +1-415-946-1066, or emily@weisscommpartners.com, for GenomicHealth, Inc.

MORE ON THIS TOPIC